Hepatocellular carcinoma (Q29615841)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article (publication date: 6 December 2003)

Language	Label	Description	Also known as
English	Hepatocellular carcinoma	scientific article (publication date: 6 December 2003)

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14667750%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

Europe PubMed Central

Hepatocellular carcinoma (English)

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14667750

30 April 2017

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14667750%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Josep M. Llovet

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14667750%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14667750%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Andrew Kenneth Burroughs

2

object named as

Andrew Burroughs

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14667750%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

language of work or name

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14667750

30 April 2017

publication date

1 December 2003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14667750%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14667750

30 April 2017

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14667750%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

362

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14667750

30 April 2017

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14667750%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

9399

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14667750

30 April 2017

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14667750%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1907-1917

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14667750%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Estimating the world cancer burden: Globocan 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Trends in primary liver cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Rising incidence of hepatocellular carcinoma in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiology of primary liver cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatocellular carcinoma in Italian patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk Factors for Hepatocellular Carcinoma among Patients with Chronic Liver Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetics of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular pathogenesis of human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B vaccination and hepatocellular carcinoma rates in boys and girls

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The challenge of developing a vaccine against hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Screening for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Adult cirrhotic liver explants: precancerous lesions and undetected small hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of the benefits and risks of percutaneous biopsy before surgical resection of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver: accuracy of ultrasonography in transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Tissue harmonic and contrast-specific imaging: back to gray scale in ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of hepatocellular carcinoma: combined T2-weighted and dynamic gadolinium-enhanced MRI versus combined CT during arterial portography and CT hepatic arteriography

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic prediction and treatment strategy in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis. Italian Cooperative HCC Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. A study in 22 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Subclinical hepatocellular carcinoma: An analysis of 391 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Early hepatocellular carcinoma as an entity with a high rate of surgical cure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural history and prognosis of adenomatous hyperplasia and early hepatocellular carcinoma: multi-institutional analysis of 53 nodules followed up for more than 6 months and 141 patients with single early hepatocellular carcinoma treated by surgica

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognosis of hepatocellular carcinoma: the BCLC staging classification

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural history of inoperable hepatocellular carcinoma: estrogen receptors' status in the tumor is the strongest prognostic factor for survival

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. The Cancer of the Liver Italian Program (CLIP) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence and prognostic value of hepatocellular carcinoma in cirrhotic patients presenting with spontaneous bacterial peritonitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Simplified staging for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatocellular carcinoma: diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Power Doppler signals after percutaneous ethanol injection therapy for hepatocellular carcinoma predict local recurrence of tumors: a prospective study using 199 consecutive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

An analysis of 412 cases of hepatocellular carcinoma at a Western center

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Preoperative predictors of survival after resection of small hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatic resection versus transplantation for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Liver transplantation for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term results of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis: a European experience

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatobiliary surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Surgery for small liver cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Surgical treatment of hepatocellular carcinoma: Experience with liver resection and transplantation in 198 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A model to predict survival in patients with end-stage liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The new liver allocation system: moving toward evidence-based transplantation policy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Model for end-stage liver disease (MELD) and allocation of donor livers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Adult-to-adult transplantation of the right hepatic lobe from a living donor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Adult living donor liver transplantation for patients with hepatocellular carcinoma: extending UNOS priority criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Living donor liver transplantation for early hepatocellular carcinoma: A life-expectancy and cost-effectiveness perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Transplantation of liver grafts from living donors into adults--too much, too soon

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Local ablation therapy for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Complications of radiofrequency coagulation of liver tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma--a comparison of lipiodol-transcatheter arterial embolization with and without adriamycin (first cooperative study). The Cooperative Study Group for Liver Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma--a comparison between L-TAE with farmorubicin and L-TAE with adriamycin: preliminary results (second cooperative study). Cooperative Study Group for Liver Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma--a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Controlled trial of tamoxifen in patients with advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of hepatocellular carcinoma with tamoxifen: A double-blind placebo-controlled trial in 120 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Tamoxifen does not improve survival of patients with advanced hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of advanced hepatocellular carcinoma with tamoxifen and the correlation with expression of hormone receptors: a prospective randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose tamoxifen in the treatment of inoperable hepatocellular carcinoma: A multicenter randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hormonal therapy with megestrol in inoperable hepatocellular carcinoma characterized by variant oestrogen receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of antiandrogen therapy in unresectable hepatocellular carcinoma: results of a European Organization for Research and Treatment of Cancer multicentric double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant interferon-α in inoperable hepatocellular carcinoma: A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized placebo-controlled study of long-acting octreotide for the treatment of advanced hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Sex hormone receptors in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914964-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(03)14964-1

3 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14667750

30 April 2017

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14667750%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

3 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14667750

30 April 2017

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14667750%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q29615841&oldid=2049205865"